JS

Jyoti Singh

Director Additional Director DIN 08021370
DIN 08021370 First appointment Dec 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Jyoti Singh

Data last updated:

Jyoti Singh was an Additional Director at Earthmed Pharmaceutical Private Limited (2017–2024) and Additional Director at Ixia Pharmaceutical Limited (2021). The companies operate in Pharma.

DIN 08021370
Primary Designation Additional Director
Industry Pharma
First Appointment 05 Dec 2017

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director05 Dec 20172017₹44 Lakh (FY 2020)Active
Ixia Pharmaceutical Limited U24110UP2021PLC149392
Additional Director01 Sep 20212021Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Earthmed Pharmaceutical Private Limited
Ixia Pharmaceutical Limited
Premium access

Shareholding and investment profile for Jyoti Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyoti Singh

Jyoti Singh was first appointed on 05 Dec 2017 as Additional Director at Earthmed Pharmaceutical Private Limited. The most recent appointment on record is 01 Sep 2021 at Ixia Pharmaceutical Limited.

Jyoti Singh held 2 earlier board appointments: Earthmed Pharmaceutical Private Limited (Additional Director, 05 Dec 2017 to 05 Nov 2024); Ixia Pharmaceutical Limited (Additional Director, 01 Sep 2021 to 27 Sep 2021).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available